Paper36906359
Chitosan particle-emulsion complex adjuvants: The effect of particle distribution on the immune intensity and response type.
Wu N and 5 others. Carbohydr Polym, 2023. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Chitosan particle-emulsion complex adjuvants: The effect of particle distribution on the immune intensity and response type. Papers, record 36906359. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36906359
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chitosan particle-emulsion complex adjuvants: The effect of particle distribution on the immune intensity and response type.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chitosan | Major topic |
| Vaccines | Major topic |
| Adjuvants, Immunologic | |
| Emulsions | |
| Immunity, Cellular | |
| Particle Size | |
| Humans | |
| Animals |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42713295 | Ultrasound-triggered chitosan interfacial crosslinking for core-shell nanoemulsions with enhanced salidroside bioaccessibility. | Food Chem X | 2026 | https://conductscience.org/library/papers/42713295 | PubMed |
| 41909730 | Tuning mechanical softness as a design principle in drug delivery: A biomechanical perspective. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41909730 | PubMed |
| 41488455 | Polymeric particle-based antigen delivery system: From immunological engineering to clinical translation. | Int J Pharm X | 2025 | https://conductscience.org/library/papers/41488455 | PubMed |
| 41235367 | Polyethyleneimine-modified Laminarin nanoparticles enhance antigen delivery to lymph nodes by inducing transient inflammatory responses at the injection site. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41235367 | PubMed |
| 40860135 | Chitosan activates NLRP3 inflammasome and cGAS-STING to suppress cancer progression through hexokinase 2 dissociation and mitochondrial dysfunction. | Theranostics | 2025 | https://conductscience.org/library/papers/40860135 | PubMed |
| 40331611 | [Research advances of liposomes and exosomes in drug delivery and biomarker screening]. | Se Pu | 2025 | https://conductscience.org/library/papers/40331611 | PubMed |
| 38258045 | Lipid-Based Nanotechnology: Liposome. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/38258045 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36906359
GET https://conductscience.org/api/papers/v1/36906359/authors